Literature DB >> 26853911

The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.

Andrzej S Pitek1, Amy M Wen1, Sourabh Shukla1, Nicole F Steinmetz1,2,3,4,5.   

Abstract

Biomolecules in bodily fluids such as plasma can adsorb to the surface of nanoparticles and influence their biological properties. This phenomenon, known as the protein corona, is well established in the field of synthetic nanotechnology but has not been described in the context of plant virus nanoparticles (VNPs). The interaction between VNPs derived from Tobacco mosaic virus (TMV) and plasma proteins is investigated, and it is found that the VNP protein corona is significantly less abundant compared to the corona of synthetic particles. The formed corona is dominated by complement proteins and immunoglobulins, the binding of which can be reduced by PEGylating the VNP surface. The impact of the VNP protein corona on molecular recognition and cell targeting in the context of cancer and thrombosis is investigated. A library of functionalized TMV rods with polyethylene glycol (PEG) and peptide ligands targeting integrins or fibrin(ogen) show different dispersion properties, cellular interactions, and in vivo fates depending on the properties of the protein corona, influencing target specificity, and non-specific scavenging by macrophages. Our results provide insight into the in vivo properties of VNPs and suggest that the protein corona effect should be considered during the development of efficacious, targeted VNP formulations.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CREKA; GPRPP; RGD; drug/contrast agent delivery; nanomedicine

Mesh:

Substances:

Year:  2016        PMID: 26853911      PMCID: PMC5147027          DOI: 10.1002/smll.201502458

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  53 in total

Review 1.  Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Authors:  Biana Godin; Jason H Sakamoto; Rita E Serda; Alessandro Grattoni; Ali Bouamrani; Mauro Ferrari
Journal:  Trends Pharmacol Sci       Date:  2010-02-19       Impact factor: 14.819

2.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 3.  Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects.

Authors:  Nicole Iverson; Nicole Plourde; Evangelia Chnari; Gary B Nackman; Prabhas V Moghe
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

4.  Mapping protein binding sites on the biomolecular corona of nanoparticles.

Authors:  Philip M Kelly; Christoffer Åberg; Ester Polo; Ann O'Connell; Jennifer Cookman; Jonathan Fallon; Željka Krpetić; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2015-03-30       Impact factor: 39.213

5.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

6.  Protein corona significantly reduces active targeting yield.

Authors:  Vahid Mirshafiee; Morteza Mahmoudi; Kaiyan Lou; Jianjun Cheng; Mary L Kraft
Journal:  Chem Commun (Camb)       Date:  2013-03-28       Impact factor: 6.222

7.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

9.  Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.

Authors:  Amy M Wen; Yunmei Wang; Kai Jiang; Greg C Hsu; Huiyun Gao; Karin L Lee; Alice C Yang; Xin Yu; Daniel I Simon; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2015-06-10       Impact factor: 6.331

10.  Nanomanufacturing of Tobacco Mosaic Virus-Based Spherical Biomaterials Using a Continuous Flow Method.

Authors:  Michael A Bruckman; Allen VanMeter; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2014-12-09
View more
  19 in total

Review 1.  Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

Authors:  Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-15       Impact factor: 4.939

2.  POxylation as an alternative stealth coating for biomedical applications.

Authors:  Herdis Bludau; Anna E Czapar; Andrzej S Pitek; Sourabh Shukla; Rainer Jordan; Nicole F Steinmetz
Journal:  Eur Polym J       Date:  2016-11-05       Impact factor: 4.598

3.  Multiple Administrations of Viral Nanoparticles Alter in Vivo Behavior-Insights from Intravital Microscopy.

Authors:  Sourabh Shukla; R Dixon Dorand; Jay T Myers; Sarah E Woods; Neetu M Gulati; Phoebe L Stewart; Ulrich Commandeur; Alex Y Huang; Nicole F Steinmetz
Journal:  ACS Biomater Sci Eng       Date:  2016-03-30

Review 4.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

5.  Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.

Authors:  He Hu; Hema Masarapu; Yuning Gu; Yifan Zhang; Xin Yu; Nicole F Steinmetz
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-10       Impact factor: 9.229

6.  Cryo-electron tomography investigation of serum albumin-camouflaged tobacco mosaic virus nanoparticles.

Authors:  Neetu M Gulati; Andrzej S Pitek; Nicole F Steinmetz; Phoebe L Stewart
Journal:  Nanoscale       Date:  2017-03-09       Impact factor: 7.790

7.  Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.

Authors:  Andrzej S Pitek; Slater A Jameson; Frank A Veliz; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomaterials       Date:  2016-02-23       Impact factor: 12.479

8.  Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio.

Authors:  Paul L Chariou; Karin L Lee; Jonathan K Pokorski; Gerald M Saidel; Nicole F Steinmetz
Journal:  J Phys Chem B       Date:  2016-04-13       Impact factor: 2.991

9.  Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells.

Authors:  Amy M Wen; Karin L Lee; Pengfei Cao; Katrina Pangilinan; Bradley L Carpenter; Patricia Lam; Frank A Veliz; Reza A Ghiladi; Rigoberto C Advincula; Nicole F Steinmetz
Journal:  Bioconjug Chem       Date:  2016-04-27       Impact factor: 4.774

Review 10.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.